Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 10,959,132	$ 14,764,346
Accounts receivable, net	825,346	943,272
Accounts receivable, related party net	269,973
Prepaid expenses and other current assets	522,938	375,360
Inventories, net	1,505,435	1,541,513
Advances on contracts	1,630,857	1,309,260
Total current assets	15,713,681	18,933,751
Furniture, fixtures and equipment, net	16,936	23,713
Intangibles, net	250,850	277,619
Right of use assets	506,849	550,511
Other assets	24,150	24,150
Total assets	16,512,466	19,809,744
Current liabilities:
Accounts payable	1,385,404	780,428
Accounts payable, related party	733,657	395,857
Accrued expenses and other payables	952,448	1,417,248
Accrued expenses, related party	222,455	414,241
Current portion of finance lease liabilities	8,946	8,545
Current portion of operating lease liabilities	86,228	81,001
Total current liabilities	3,389,138	3,097,320
Non-current portion of finance lease liabilities	15,487	20,062
Non-current portion of operating lease liabilities	432,180	476,980
Total liabilities	3,836,805	3,594,362
Commitments
Stockholders’ equity
Common stock, par value $.001;authorized 100,000,000 shares; 68,811,482 and 68,153,336 shares issued at June 30, 2022 and December 31, 2021 and 68,778,149 and 68,120,003 shares outstanding as June 30, 2022 and December 31, 2021, respectively	68,811	68,153
Additional paid in capital	126,175,735	124,915,560
Accumulated deficit	(112,464,478)	(107,704,274)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	12,868,552	16,367,923
Noncontrolling interest	(192,891)	(152,541)
Total stockholders’ equity	12,675,661	16,215,382
Total liabilities and stockholders’ equity	$ 16,512,466	$ 19,809,744